Free Trial
→ Musk threatens Liberal’s fake “energy crisis” (From Porter & Company) (Ad) Free YSBPW Stock Alerts

YS Biopharma (YSBPW) SEC Filings & 10K Form

$0.05 +0.01 (+27.78%)
(As of 12/17/2024 ET)
Compare

Recent YS Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
12/12/2024
3:10 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:01 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:16 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
7:59 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
3:00 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
6:01 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
6:45 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:30 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
3:16 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
7:32 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
04/29/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:03 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:20 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
7:10 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
7:06 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:17 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
7:25 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
3:14 PM		YS Biopharma Co., Ltd. (Subject)
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
Zhang /MD Yi (Filed by)
Form SC 13G/A
02/14/2024
10:23 AM		Wong Fung Ching (Filed by)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
Form SC 13D
02/14/2024
6:59 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:01 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:05 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
6:10 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/25/2024
11:15 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form EFFECT
01/26/2024
5:03 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2024
3:18 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form POS AM
01/22/2024
4:10 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
6:10 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
11:43 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
How to piss off your liberal friends… and profit from it (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:YSBPW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...
Banyan Hill Publishing | Sponsored
How this >10-cent coin is going to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
Please don’t take this warning lightly…
Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...
InvestorPlace | Sponsored
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Behind the Markets | Sponsored
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored